SNRIs: Mechanism, Uses, Side Effects & Clinical Pearls

Mechanism

Block serotonin transporter (SERT) and norepinephrine transporter (NET) → ↑ synaptic 5-HT & NE → downstream neuroplasticity (BDNF, mTOR) → antidepressant/analgesic effect.

Agents & NE/5-HT Ratio

  • Venlafaxine: Low dose = SSRI-like; ≥150 mg = SNRI
  • Duloxetine: Balanced (1:10 NE:5-HT)
  • Desvenlafaxine: Similar to venlafaxine
  • Levomilnacipran: NE-preferring
  • Milnacipran: NE-preferring (approved for fibromyalgia)

Indications

  • MDD, GAD, panic disorder, social anxiety
  • Chronic pain: diabetic neuropathy, fibromyalgia, chronic musculoskeletal (duloxetine, milnacipran)
  • Stress urinary incontinence (duloxetine — ex-US)

Side Effects

  • Nausea (transient, dose-related)
  • Hypertension (dose-dependent, monitor)
  • Sexual dysfunction, insomnia, diaphoresis, constipation
  • Discontinuation syndrome (taper over 2–4 wks)

Onset

2–4 weeks for initial response; 6–8 weeks for full effect.

Prescription Medications - Related Articles